Lysophosphatidylcholine

There are 67 papers on lysophosphatidylcholine in aging research: 5 trials and 36 observational studies in people, 23 in animals, 1 in cells, 2 reviews.

Biomarker

67 papers study it49 more mention it19 findings

MeSH

4 new papers in 30 daysSee all 116 papers on lysophosphatidylcholine

“In men and the pooled sample, WMH were also associated with lower levels of lysophosphatidylcholines and hydroxysphingomyelins”
Circulating Metabolome and White Matter Hyperintensities in Women and MenCirculation2022doi:10.1161/circulationaha.121.056892
  • Human trial5
  • Humans36
  • Animals20
  • Model organisms3
  • Cells1

Interventions

1

Aerobic exercise

upin mice1

1 study
  1. Aerobic exercise increases lysophosphatidylcholine in mice (APP/PS1 Alzheimer's disease model mice, compared with the AD model group).

    “98 different metabolites were found between the AM and AE groups, 41 of which were upregulated such as Lyso phosphatidylcholine (LysoPC)”

    AnimalsAPP/PS1 Alzheimer's disease model mice, compared with the AD model grouprunning platform exercisececum contentsmoderate intensity20 weeksmalesn = 6

    Mass Spectrometry Chromatography-Based Metabolomics: The Effect of Long-Term Aerobic Exercise on Learning Ability and the Metabolism of Intestinal Contents in Mice with Alzheimer's Disease

    Metabolites

More on Aerobic exercise

Effects

1

Circulating levels

downin mice1

1 study
  1. Lysophosphatidylcholine decreases circulating levels in mice during aging.

    “the microbiota-associated depletion of protective circulating metabolites, such as lysophosphatidylcholines (LPCs)”

    Animalsduring agingserum

    A Multi-Organ Atlas Links Gut Microbial Metabolites to Systemic Redox Changes in Aging Mice

    Aging cell

More on Circulating levels

Upstream

5

Sepsis

downin humans1

1 study
  1. Sepsis is linked with lower lysophosphatidylcholine in sepsis patients (P<0.05).

    “Sepsis patients exhibited reduced phosphatidylcholine (PC), cholesteryl ester (CE), and lysophosphatidylcholine (LPC) levels (all P<0.05).”

    Humansin sepsis patientsn = 62

    Plasma lipidomic signatures reveal age-associated patterns of septic shock risk and immune dysregulation in sepsis

    Frontiers in immunology

More on Sepsis

Parity

downin cattle1

1 study
  1. Parity decreases lysophosphatidylcholine in cattle.

    “phospholipids with 40:5 and 38:6, lysophosphatidylcholine (17:0), SM(35:1), and SM(35:2) were commonly identified lipids that decreased in concentration with parity and age.”

    Animalsplasma

    A large multisite lipidomic investigation of parity and aging in dairy cows

    Journal of dairy science

Age

downin mice1

1 study
  1. Age decreases lysophosphatidylcholine in mice (young (7 weeks) versus aged (84 weeks) C57BL/6 mice) (significant decrease).

    “circulating lysophosphatidylcholine and lysophosphatidylethanolamine levels showed a significant decrease”

    Animalsyoung (7 weeks) versus aged (84 weeks) C57BL/6 miceplasma

    Exercise-induced recovery of plasma lipids perturbed by ageing with nanoflow UHPLC-ESI-MS/MS

    Analytical and bioanalytical chemistry

Alzheimer's disease

upin humans1

1 study
  1. Alzheimer's disease is linked with higher lysophosphatidylcholine in humans.

    “Notably, we observed similar but more pronounced changes in the group that developed probable AD.”

    Humansmore pronounced than the change with normal aging, in participants who developed probable Alzheimer's disease90 months

    Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging

    Journal of Alzheimer's disease : JAD

More on Alzheimer's disease

Normal aging

upin humans1

1 study
  1. Normal aging is linked with higher lysophosphatidylcholine in humans.

    “during normal aging the levels of lysophosphatidylcholine, choline plasmalogen, and lyso-platelet activating factor increase significantly”

    Humans90 months

    Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging

    Journal of Alzheimer's disease : JAD

Associations

12

Alzheimer's disease

downin humans1

1 study
  1. Alzheimer's disease is associated with lysophosphatidylcholine in humans.

    “allowing precise mapping of LysoPC (16:0) deficits as a biomarker and therapeutic target across aging, Alzheimer's disease, and perioperative neurocognitive impairment.”

    Humansserum

    Machine-Learning-Assisted Triple-Gated Raman Enhancement Platform for Selectively Quantifying Lysophosphatidylcholine (16:0) as a Potential Biomarker for Cognitive Impairments

    ACS nano

More on Alzheimer's disease

Machine learning

upin silico1

1 study
  1. machine learning predicts lysophosphatidylcholine in silico (R2 = 0.999).

    “Coupled with machine-learning extraction of Raman fingerprints, ZrS2@ZrOx-C16 achieves rapid, label-free quantification with an accuracy of R2 = 0.999 across human and mouse serum samples”

    In silicoserum

    Machine-Learning-Assisted Triple-Gated Raman Enhancement Platform for Selectively Quantifying Lysophosphatidylcholine (16:0) as a Potential Biomarker for Cognitive Impairments

    ACS nano

Postmenopausal bone loss

downin humans1

1 study
  1. Lysophosphatidylcholine is associated with postmenopausal bone loss in humans.

    “higher levels of flavonoids (taxifolin), L-arginine, and spermidine in the normal bone group and reduced lysophosphatidylcholine levels”

    Humansserumfemalesn = 105

    Altered gut microbiota and serum metabolite profiles characterize postmenopausal bone loss: insights into the gut-bone axis

    Frontiers in microbiology

More on Postmenopausal bone loss

Female sex

downin mice1

1 study
  1. Female sex is associated with lysophosphatidylcholine in mice.

    “Spleens from female mice had lower levels of lysophosphatidylcholine and lysophosphatidylethanolamine compared to males.”

    Animalsspleenfemales

    The aging mouse lipidome

    bioRxiv : the preprint server for biologyPreprint

Metabolic events

upin humans1

1 study
  1. Lysophosphatidylcholine is linked with a higher risk of metabolic events in humans (post-SVR in HIV/HCV-coinfected participants with cACLD).

    “Lysophosphatidylcholines (LPCs) were the most prevalent, with higher baseline levels linked to increased metabolic risk.”

    Humanspost-SVR in HIV/HCV-coinfected participants with cACLDplasman = 56

    Lipid and immune dysregulation and risk of metabolic disorders after HCV clearance in HIV/HCV-coinfected participants with cACLD: a retrospective study

    Frontiers in immunology

More on Metabolic events

Low handgrip strength

upin humans1OR 2.46

1 study
  1. Lysophosphatidylcholine is linked with a higher risk of low handgrip strength in adjusted models, lowest tertile vs highest tertile (OR: 2.46; 95% CI: 1.02-5.94; p = 0.045).

    “the lowest tertile exhibited higher odds of low HGS for total LPC (OR: 2.46; 95% confidence interval [CI]: 1.02-5.94; p = 0.045)”

    Humansin adjusted models, lowest tertile vs highest tertileplasman = 185

    Low Plasma Lysophosphatidylcholine Levels Are Associated With Reduced Handgrip Strength in Older Outpatients

    Geriatrics & gerontology international

Parkinson's disease progression

upin humans1

1 study
  1. Parkinson's disease progression is associated with lysophosphatidylcholine in humans (Parkinson's disease).

    “Lyso-phosphatidylcholine increased progressively throughout PD progression.”

    HumansParkinson's diseasebrain

    Multi-omic analysis reveals lipid dysregulation associated with mitochondrial dysfunction in parkinson's disease brain

    Nature communications

Mortality

downin humans1

1 study
  1. Lysophosphatidylcholine is associated with mortality in humans.

    “higher levels of the majority of LPC species were associated with lower mortality risks”

    Humansn = 3,462

    Methods for joint modeling of longitudinal omics data and time-to-event outcomes: applications to lysophosphatidylcholines in connection to aging and mortality in the Long Life Family Study

    Aging

Physical activity

upin humans1

1 study
  1. Physical activity is associated with lysophosphatidylcholine in humans.

    “higher circulating levels of lysophosphatidylcholines that have been previously associated with better mitochondrial oxidative capacity”

    Humans

    Serum Proteomic and Metabolomic Signatures of High Versus Low Physical Function in Octogenarians

    Aging cell

More on Physical activity

White matter hyperintensities

downin humans1

1 study
  1. Lysophosphatidylcholine is associated with white matter hyperintensities in humans (basic and fully adjusted models).

    “In men and the pooled sample, WMH were also associated with lower levels of lysophosphatidylcholines and hydroxysphingomyelins”

    Humansbasic and fully adjusted models

    Circulating Metabolome and White Matter Hyperintensities in Women and Men

    Circulation

All 12

Funding

1 grant since 2020

National Heart, Lung, and Blood Institute$246K

Latest

Dec 2025: 2Jan 2026: 7Feb 2026: 2Mar 2026: 5Apr 2026: 0May 2026: 0Jun 2026: 2Jul 2026: 2Aug 2026: 1Sep 2026: 7Oct 2026: 4Nov 2026: 133 papers in 12 months

See all 116 papers on lysophosphatidylcholine